Catalyst dives as FDA approves rival's rare disease drug

Catalyst dives as FDA approves rival's rare disease drug

Submitted by admin on May 7, 2019 - 6:58pm
Source: 
Biopharma Dive
News Tags: 
FDA
Catalyst Pharmaceutical Partners
Jacobus Pharmaceuticals
Ruzurgi
Firdapse
LEMS
Headline: 
Catalyst dives as FDA approves rival's rare disease drug
snippet: 

The Food and Drug Administration has approved a rare disease drug from family-owned Jacobus Pharmaceutical, a decision that could present a competitive threat to Catalyst Pharmaceuticals.